Description

CJC-1295 No DAC is a synthetic growth hormone-releasing hormone analogue developed for laboratory investigations involving endocrine signaling and peptide-mediated hormonal regulation within controlled research environments. Unlike DAC-modified variants, this formulation is designed for shorter-duration biological activity, making it valuable in studies examining pulsatile endocrine signaling mechanisms and receptor-targeted peptide communication pathways. Researchers investigate CJC-1295 No DAC for its interaction with biological pathways associated with pituitary receptor activation, growth hormone secretion dynamics, IGF-1 signaling activity, and metabolic communication processes. The peptide is frequently utilized in laboratory studies examining endocrine pathway modulation, receptor-mediated signaling activity, and peptide-driven hormonal communication across advanced experimental research models. Researchers also study its structural stability and controlled biological signaling characteristics under laboratory conditions requiring shorter-duration receptor interaction analysis. Due to its endocrine signaling profile and receptor-targeted biological activity, the peptide has gained significant attention in advanced hormonal pathway investigations involving peptide-mediated communication systems. Each vial is supplied as research-grade lyophilized material manufactured under controlled laboratory standards with verified purity and analytical testing protocols supporting consistency, structural integrity, and reliability in scientific peptide research applications.

Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂
Molecular Weight: 3367.89 g/mol
Storage: Store lyophilized at −20°C under sterile laboratory conditions

FOR RESEARCH USE ONLY